Ana Rodrigo‐Troyano

1.3k total citations
30 papers, 545 citations indexed

About

Ana Rodrigo‐Troyano is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, Ana Rodrigo‐Troyano has authored 30 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 7 papers in Epidemiology and 5 papers in Physiology. Recurrent topics in Ana Rodrigo‐Troyano's work include Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Cystic Fibrosis Research Advances (8 papers) and Respiratory and Cough-Related Research (5 papers). Ana Rodrigo‐Troyano is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Cystic Fibrosis Research Advances (8 papers) and Respiratory and Cough-Related Research (5 papers). Ana Rodrigo‐Troyano collaborates with scholars based in Spain, United Kingdom and United States. Ana Rodrigo‐Troyano's co-authors include Oriol Sibila, James D. Chalmers, Guillermo Suárez-Cuartín, Lídia Perea, Marcos I. Restrepo, Vicente Plaza, Diego Castillo, Amelia Shoemark, Holly R. Keir and Noé Garín and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Scientific Reports.

In The Last Decade

Ana Rodrigo‐Troyano

28 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Rodrigo‐Troyano Spain 12 257 133 83 74 69 30 545
Rebecca S. Pettit United States 14 255 1.0× 150 1.1× 47 0.6× 123 1.7× 32 0.5× 40 544
Lisa Lubsch United States 10 599 2.3× 172 1.3× 109 1.3× 85 1.1× 35 0.5× 17 840
Michael F. Canarie United States 10 87 0.3× 97 0.7× 48 0.6× 42 0.6× 14 0.2× 16 451
Jeffery T. Zobell United States 15 369 1.4× 239 1.8× 53 0.6× 162 2.2× 21 0.3× 32 576
Nancy Smith United States 13 84 0.3× 90 0.7× 54 0.7× 43 0.6× 21 0.3× 22 598
Kübra Aykaç Türkiye 14 106 0.4× 182 1.4× 70 0.8× 64 0.9× 13 0.2× 56 616
L. Minicucci Italy 15 326 1.3× 62 0.5× 111 1.3× 69 0.9× 8 0.1× 39 562
Robert Press United States 13 125 0.5× 193 1.5× 102 1.2× 45 0.6× 12 0.2× 19 797
Luis S. Gonzalez United States 8 25 0.1× 86 0.6× 51 0.6× 49 0.7× 46 0.7× 13 370
R Kubin Germany 13 228 0.9× 475 3.6× 21 0.3× 121 1.6× 35 0.5× 13 694

Countries citing papers authored by Ana Rodrigo‐Troyano

Since Specialization
Citations

This map shows the geographic impact of Ana Rodrigo‐Troyano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Rodrigo‐Troyano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Rodrigo‐Troyano more than expected).

Fields of papers citing papers by Ana Rodrigo‐Troyano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Rodrigo‐Troyano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Rodrigo‐Troyano. The network helps show where Ana Rodrigo‐Troyano may publish in the future.

Co-authorship network of co-authors of Ana Rodrigo‐Troyano

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Rodrigo‐Troyano. A scholar is included among the top collaborators of Ana Rodrigo‐Troyano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Rodrigo‐Troyano. Ana Rodrigo‐Troyano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castillo, Diego, et al.. (2022). [Translated article] Study of diffuse interstitial lung disease with the analysis of volatile particles in exhaled air. Archivos de Bronconeumología. 58(1). T99–T101. 2 indexed citations
2.
Rodrigo‐Troyano, Ana, Jordi Giner, Lídia Perea, et al.. (2022). Predicting Early Hospital Readmissions in COPD Patients Using an Electronic Nose. Archivos de Bronconeumología. 58(9). 663–665. 1 indexed citations
4.
Castillo, Diego, et al.. (2021). Estudio de la enfermedad pulmonar intersticial difusa mediante el análisis de partículas volátiles en el aire exhalado. Archivos de Bronconeumología. 58(1). 99–101. 1 indexed citations
5.
Perea, Lídia, Ana Rodrigo‐Troyano, Elisabet Cantó, et al.. (2020). Reduced airway levels of fatty-acid binding protein 4 in COPD: relationship with airway infection and disease severity. Respiratory Research. 21(1). 21–21. 5 indexed citations
6.
Sibila, Oriol, Elena Laserna, Amelia Shoemark, et al.. (2019). Airway Bacterial Load and Inhaled Antibiotic Response in Bronchiectasis. American Journal of Respiratory and Critical Care Medicine. 200(1). 33–41. 74 indexed citations
7.
Laserna, Elena, Amelia Shoemark, Holly R. Keir, et al.. (2019). Airway Bacterial Load and Response to Inhaled Aztreonam in Bronchiectasis. A5714–A5714. 1 indexed citations
8.
Rodrigo‐Troyano, Ana, et al.. (2018). Safety of a Modified Protocol of Bronchial Thermoplasty. Archivos de Bronconeumología. 54(6). 345–346. 2 indexed citations
9.
Suárez-Cuartín, Guillermo, Jordi Giner, José Luís Merino, et al.. (2018). Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis. Respiratory Medicine. 136. 111–117. 18 indexed citations
10.
Cantó, Elisabet, Emma Roca, Lídia Perea, et al.. (2018). Salivary immunity and lower respiratory tract infections in non-elite marathon runners. PLoS ONE. 13(11). e0206059–e0206059. 16 indexed citations
11.
Rodrigo‐Troyano, Ana, Pedro J. Marcos, Elena Laserna, et al.. (2018). <b><i>Pseudomonas aeruginosa</i></b> in Chronic Obstructive Pulmonary Disease Patients with Frequent Hospitalized Exacerbations: A Prospective Multicentre Study. Respiration. 96(5). 417–424. 39 indexed citations
12.
Perea, Lídia, Elisabet Cantó, Guillermo Suárez-Cuartín, et al.. (2018). Antimicrobial peptides and airway bacterial colonization in bronchiectasis. OA4948–OA4948. 1 indexed citations
13.
Rodrigo‐Troyano, Ana & Oriol Sibila. (2017). The respiratory threat posed by multidrug resistant Gram‐negative bacteria. Respirology. 22(7). 1288–1299. 94 indexed citations
14.
Rodrigo‐Troyano, Ana, et al.. (2017). Heart failure induced by itraconazole. Medicina Clínica (English Edition). 148(2). 69–70. 2 indexed citations
15.
Rodrigo‐Troyano, Ana, Guillermo Suárez-Cuartín, Diego Castillo, et al.. (2016). Pseudomonas aeruginosa resistance patterns and clinical outcomes in hospitalized exacerbations of COPD. Respirology. 21(7). 1235–1242. 38 indexed citations
16.
Sibila, Oriol, Ana Rodrigo‐Troyano, & Antoní Torres. (2016). Nonantibiotic Adjunctive Therapies for Community-Acquired Pneumonia (Corticosteroids and Beyond): Where Are We with Them?. Seminars in Respiratory and Critical Care Medicine. 37(6). 913–922. 7 indexed citations
17.
Sibila, Oriol, Jordi Giner, Ana Rodrigo‐Troyano, et al.. (2016). Airway Mucin 2 Is Decreased in Patients with Severe Chronic Obstructive Pulmonary Disease with Bacterial Colonization. Annals of the American Thoracic Society. 13(5). 636–642. 18 indexed citations
18.
Sibila, Oriol, Ana Rodrigo‐Troyano, Yuichiro Shindo, Stefano Aliberti, & Marcos I. Restrepo. (2016). Multidrug-resistant pathogens in patients with pneumonia coming from the community. Current Opinion in Pulmonary Medicine. 22(3). 219–226. 26 indexed citations
19.
Sibila, Oriol, Guillermo Suárez-Cuartín, Ana Rodrigo‐Troyano, et al.. (2015). Secreted mucins and airway bacterial colonization in non‐CF bronchiectasis. Respirology. 20(7). 1082–1088. 40 indexed citations
20.
Rodrigo‐Troyano, Ana, Guillermo Suárez-Cuartín, Diego Castillo, et al.. (2015). Acute exacerbations of COPD due topseudomonas aeruginosa: Impact of antimicrobial resistance. OA4753–OA4753.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026